El robot Zhurong explora la superficie marciana
En este Short recordamos el periplo marciano del robot chino Zhurong. …
Uncategorized
Success for Surglasses Technology! First AR Surgery Completed in the United States
Surglasses/Caduceus S from Taiwan Main Orthopaedic Biotechnology Co., Ltd. Achieves Landmark Success with Caduceus S AR Spine Navigation System for First Augmented Reality Surgery in the US using 2D C-Arm Imaging.
Success for Surglasses Technology! First AR Surgery Completed in the United States Read More »
Acadia Awaits Potential Approval of First Rett Syndrome Medicine
The FDA is set to make a decision on trofinetide, which Acadia is developing with partner Neuren Pharmaceuticals, on March 12.
Acadia Awaits Potential Approval of First Rett Syndrome Medicine Read More »
Diamyd Medical brings Karin Rosén, M.D, PhD, to its Board of Directors
Diamyd Medical announced that Karin Rosén, M.D, Ph.D, San Francisco, will join the Board of Directors as an adjunct member, and be proposed for election to the Board at its next General Meeting of Shareholders.
Diamyd Medical brings Karin Rosén, M.D, PhD, to its Board of Directors Read More »
LEO Pharma and ICON Enter a Strategic Partnership to Propel Clinical Trial Execution Within Medical Dermatology
LEO Pharma and ICON plc announced a strategic partnership that will enable LEO Pharma to scale clinical trial execution that is patient-centric and cost effective, and which will support the company’s overall ambition of building one of the most effective and efficient clinical portfolio execution organisations in the industry.
Allorion Therapeutics, a next-generation precision medicine company focusing on oncology and autoimmune diseases, raises $50 million Series B financing
Allorion Therapeutics (“Allorion”), a biotech company focusing on next-generation precision medicine for oncology and autoimmune diseases, announces the completion of a $50 million Series B financing round.
InnoCare Announces First Subject Dosed in Clinical Trial of BCL2 Inhibitor ICP-248 in China
InnoCare Pharma announced today that the first subject has been dosed in clinical trial of the Company’s B-cell lymphoma-2 (BCL2) inhibitor ICP-248 in China.
AusperBio Announces First-in-Human Dosing of AHB-137, an Antisense Oligonucleotide Drug Candidate for the Treatment of Chronic Hepatitis B
Ausper Biopharma Co., Ltd. and AusperBio Therapeutic, Inc. today announced the completion of the first cohort dosing in a Phase 1 clinical trial evaluating AHB–137 in adult healthy volunteers and chronic hepatitis B (CHB) patients in New Zealand.
Biden’s proposed HHS budget aims to make pandemic-era subsidies permanent
Released Thursday, the budget also proposes to extend Medicare solvency and give the federal government more power to negotiate prescription drug prices.
Biden’s proposed HHS budget aims to make pandemic-era subsidies permanent Read More »
Telehealth use rose at end of last year, Fair Health finds
COVID-19 stayed as the third top telehealth diagnosis nationally and accounted for a larger share of claims in December, Fair Health found.
Telehealth use rose at end of last year, Fair Health finds Read More »